- Article
EpCAM- and EGFR-Specific Antibody Drug Conjugates for Triple-Negative Breast Cancer Treatment
- Chaoyu Zhang,
- Wenjie Sheng,
- Marwah Al-Rawe,
- T. M. Mohiuddin,
- Marcus Niebert,
- Felix Zeppernick,
- Ivo Meinhold-Heerlein and
- Ahmad Fawzi Hussain
Triple-negative breast cancer (TNBC) is a group of heterogeneous and refractory breast cancers with the absence of estrogen receptor (ER), progesterone receptor (PgR) and epidermal growth factor receptor 2 (HER2). Over the past decade, antibody drug...